SB

Sangon Biotech

Shanghai, China

About

Sangon Biotech Co. (生工生物) is engaged in the research and development of chemical synthesis of DNA. It is a high-tech Sino-foreign joint venture established in 2003. After ten years of development, Sangon has become a professional biotechnology company that integrates research and development. Chemical synthesis DNA earned reputation for Sangon in the global market. In 2006, Sangon invested 50 million to build a manufacturing and industrial base in Songjiang Industrial Park, which has been put into use. Sangon produces various products such as DNA synthesis, DNA sequencing, Gene Synthesis, peptide synthesis, chemical agents, enzymes, molecular biology kit, cultivation medium, lab consumptive material, and miniature instruments.

Position in the VCSift Database

  • 4,609 investors in VCSift focus on the biotech sector.
  • 1,074 investors are based in Shanghai, Shanghai, China.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Sectors
biotech

Contact Information

sa••••@sangon.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Sangon

Search Investors